Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.

× No keyword cloud information.

16 in total

Review 1. New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.

Authors: Shannon M Bates; Jeffrey I Weitz
Journal: Br J Pharmacol Date: 2005-04 Impact factor: 8.739

2. Recombinant human soluble thrombomodulin reduces the severity and incidence of necrotizing enterocolitis in a newborn rat model.

Authors: Bo Li; Ryuta Saka; Yuichi Takama; Takehisa Ueno; Yuko Tazuke; Hiroomi Okuyama
Journal: Surg Today Date: 2019-06-12 Impact factor: 2.549

3. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.

Authors: Hisayuki Yokoyama; Naoto Takahashi; Yuna Katsuoka; Mitsue Inomata; Toshihiro Ito; Kuniaki Meguro; Yoshihiro Kameoka; Riko Tsumanuma; Kazunori Murai; Hideyoshi Noji; Kenichi Ishizawa; Shigeki Ito; Yasushi Onishi; Hideo Harigae
Journal: Int J Hematol Date: 2017-02-07 Impact factor: 2.490

4. Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.

Authors: Tomohiro Koga; Daisuke Inoue; Akitomo Okada; Toshiyuki Aramaki; Satoshi Yamasaki; Munetoshi Nakashima; Atsushi Kawakami; Katsumi Eguchi
Journal: Rheumatol Int Date: 2011-01-15 Impact factor: 2.631

5. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis.

Authors: Masaki Yamamoto; Tsukasa Hori; Naoki Hatakeyama; Keita Igarashi; Natsuko Inazawa; Hiroyuki Tsutsumi; Nobuhiro Suzuki
Journal: Indian J Pediatr Date: 2013-08-03 Impact factor: 1.967

6. Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.

Authors: T Ikezoe; J Yang; C Nishioka; A Yokoyama
Journal: Bone Marrow Transplant Date: 2014-09-22 Impact factor: 5.483

Review 7. Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome.

Authors: Robert MacLaren; Kathleen A Stringer
Journal: Pharmacotherapy Date: 2007-06 Impact factor: 4.705

8. Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation.

Authors: Kazutaka Takagi; Toshiki Tasaki; Takahiro Yamauchi; Hiromichi Iwasaki; Takanori Ueda
Journal: Case Rep Hematol Date: 2011-08-02

9. Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.

Authors: Takashi Tagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal: Front Med (Lausanne) Date: 2015-02-26

10. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.

Authors: Qute Choi; Ki Ho Hong; Ji-Eun Kim; Hyun Kyung Kim
Journal: Ann Lab Med Date: 2014-02-13 Impact factor: 3.464